Achilles Therapeutics plc - ADR

The momentum for this stock is not very good. Achilles Therapeutics plc - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Achilles Therapeutics plc - ADR.

News

Achilles Therapeutics plc (NASDAQ:ACHL) Short Interest Down 56.3% in August

Zolmax Achilles Therapeutics plc (NASDAQ:ACHL - Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling...\n more…

Achilles Therapeutics plc (NASDAQ:ACHL) Short Interest Update

Ticker Report Achilles Therapeutics plc (NASDAQ:ACHL - Get Free Report) was the recipient of a significant drop in short interest in August. As of August 15th, there was short interest totalling 8,400 shares, a...\n more…

Achilles Therapeutics (NASDAQ:ACHL) Issues Quarterly Earnings Results

Zolmax Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.41) earnings per share for the quarter, meeting analysts' consensus...\n more…

Achilles Therapeutics (NASDAQ:ACHL) Announces Quarterly Earnings Results

Ticker Report Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.41) earnings per share for the quarter, meeting analysts' consensus estimates...\n more…

Reviewing Achilles Therapeutics (NASDAQ:ACHL) and MeiraGTx (NASDAQ:MGTX)

Ticker Report Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) and MeiraGTx (NASDAQ:MGTX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two...\n more…

ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nACHL stock results show that Achilles Therapeutics met analyst estimates for earnings per share the second quarter of 2024.\nThe post...\n more…